NCI Grant Supports Artificial Intelligence for Breast Cancer Research
If you’re a scientist researching breast cancer and you use artificial intelligence (AI), there are opportunities for grant funding that can help you accomplish big things! Check out this article to learn more about a recently awarded grant.
Researchers from Rensselaer Polytechnic Institute (RPI) and Albany Medical College received a five-year grant from the National Cancer Institute’s (NCI) Division of Cancer Treatment and Diagnosis (DCTD).
With this grant, the researchers aim to:
- continue their research into how AI can assist in treating breast cancer.
- gain a better understanding of mechanisms of drug therapy resistance in HER2-positive breast cancer.
- use mesoscopic fluorescence molecular tomography to analyze tumor heterogeneities.
- develop imaging technology to allow biologists and clinicians to see how a drug binds to a tumor.
The goal is to provide researchers and clinicians with a better understanding of how tumors adapt and change during treatment, which would improve the effectiveness of drug therapy for breast cancer.
Dr. Brian Sorg, branch chief of DCTD’s Diagnostic Biomarkers and Technology Branch in the Cancer Diagnosis Program, says, “funding for research like this, that involves the integration of cutting-edge imaging technologies with AI for use in preclinical models, will improve how we assess and treat cancer in the clinic.”
If you’re seeking funding for your cancer research, bookmark NCI’s research funding opportunities webpage and check back regularly. You can also subscribe to our weekly email update, where we share relevant news and new funding opportunities.